Cargando…
Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer
Medical digital twins, which represent medical assets, play a crucial role in connecting the physical world to the metaverse, enabling patients to access virtual medical services and experience immersive interactions with the real world. One serious disease that can be diagnosed and treated using th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136137/ https://www.ncbi.nlm.nih.gov/pubmed/37106642 http://dx.doi.org/10.3390/bioengineering10040455 |
_version_ | 1785032144081387520 |
---|---|
author | Moztarzadeh, Omid Jamshidi, Mohammad (Behdad) Sargolzaei, Saleh Jamshidi, Alireza Baghalipour, Nasimeh Malekzadeh Moghani, Mona Hauer, Lukas |
author_facet | Moztarzadeh, Omid Jamshidi, Mohammad (Behdad) Sargolzaei, Saleh Jamshidi, Alireza Baghalipour, Nasimeh Malekzadeh Moghani, Mona Hauer, Lukas |
author_sort | Moztarzadeh, Omid |
collection | PubMed |
description | Medical digital twins, which represent medical assets, play a crucial role in connecting the physical world to the metaverse, enabling patients to access virtual medical services and experience immersive interactions with the real world. One serious disease that can be diagnosed and treated using this technology is cancer. However, the digitalization of such diseases for use in the metaverse is a highly complex process. To address this, this study aims to use machine learning (ML) techniques to create real-time and reliable digital twins of cancer for diagnostic and therapeutic purposes. The study focuses on four classical ML techniques that are simple and fast for medical specialists without extensive Artificial Intelligence (AI) knowledge, and meet the requirements of the Internet of Medical Things (IoMT) in terms of latency and cost. The case study focuses on breast cancer (BC), the second most prevalent form of cancer worldwide. The study also presents a comprehensive conceptual framework to illustrate the process of creating digital twins of cancer, and demonstrates the feasibility and reliability of these digital twins in monitoring, diagnosing, and predicting medical parameters. |
format | Online Article Text |
id | pubmed-10136137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101361372023-04-28 Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer Moztarzadeh, Omid Jamshidi, Mohammad (Behdad) Sargolzaei, Saleh Jamshidi, Alireza Baghalipour, Nasimeh Malekzadeh Moghani, Mona Hauer, Lukas Bioengineering (Basel) Article Medical digital twins, which represent medical assets, play a crucial role in connecting the physical world to the metaverse, enabling patients to access virtual medical services and experience immersive interactions with the real world. One serious disease that can be diagnosed and treated using this technology is cancer. However, the digitalization of such diseases for use in the metaverse is a highly complex process. To address this, this study aims to use machine learning (ML) techniques to create real-time and reliable digital twins of cancer for diagnostic and therapeutic purposes. The study focuses on four classical ML techniques that are simple and fast for medical specialists without extensive Artificial Intelligence (AI) knowledge, and meet the requirements of the Internet of Medical Things (IoMT) in terms of latency and cost. The case study focuses on breast cancer (BC), the second most prevalent form of cancer worldwide. The study also presents a comprehensive conceptual framework to illustrate the process of creating digital twins of cancer, and demonstrates the feasibility and reliability of these digital twins in monitoring, diagnosing, and predicting medical parameters. MDPI 2023-04-07 /pmc/articles/PMC10136137/ /pubmed/37106642 http://dx.doi.org/10.3390/bioengineering10040455 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moztarzadeh, Omid Jamshidi, Mohammad (Behdad) Sargolzaei, Saleh Jamshidi, Alireza Baghalipour, Nasimeh Malekzadeh Moghani, Mona Hauer, Lukas Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title | Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title_full | Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title_fullStr | Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title_full_unstemmed | Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title_short | Metaverse and Healthcare: Machine Learning-Enabled Digital Twins of Cancer |
title_sort | metaverse and healthcare: machine learning-enabled digital twins of cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136137/ https://www.ncbi.nlm.nih.gov/pubmed/37106642 http://dx.doi.org/10.3390/bioengineering10040455 |
work_keys_str_mv | AT moztarzadehomid metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT jamshidimohammadbehdad metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT sargolzaeisaleh metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT jamshidialireza metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT baghalipournasimeh metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT malekzadehmoghanimona metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer AT hauerlukas metaverseandhealthcaremachinelearningenableddigitaltwinsofcancer |